EPL

EPL Limited announced that the Competition Commission of India (CCI) has approved the Scheme of Amalgamation, involving the merger by absorption of Indovida India Private Limited with EPL. The approval was conveyed via a letter dated May 26, 2026. This follows the Board's approval of the scheme on March 29, 2026, subject to regulatory clearances.

EPL Limited reported strong Q4 FY26 performance with 17.6% revenue growth and 17.2% EBITDA growth, marking the fourth consecutive quarter of double-digit growth. The Beauty & Cosmetics segment recorded 30% YoY growth, with Oral Care growing 10%. The company sustained EBITDA margins above 20% (20.2% in Q4, 20.4% for full year) and reduced net debt to EBITDA to 0.52x. Management reaffirmed its long-term revenue growth guidance of 11-13% and anticipates EBITDA growth slightly ahead of revenue. Despite the Middle East crisis impacting raw material costs, the company is confident in full cost pass-through without lag and expects robust absolute EBITDA growth. FY27 capex is projected to be slightly elevated for market share gains. The transformative merger with Indovida is expected to complete by Q4 FY27, creating a nearly $1 billion platform and being margin accretive. Dividends are on hold until the merger's completion. The company remains active in seeking inorganic growth opportunities and expects volumes from its Thailand plant to scale gradually in FY27.

EPL Limited's Board of Directors, at its meeting on May 14, 2026, approved the re-appointment of M/s. Jitendrakumar & Associates as Cost Auditors for the Financial Year 2026-27. Additionally, Mr. Vinay Thakur was appointed as the Internal Auditor of the Company, effective May 14, 2026.

Consolidated Revenue ₹10,790Mn vs ₹9,994Mn (▲7.96% YoY), EBITDA ₹818Mn vs ₹1,239Mn (▼34.00% YoY), PAT ₹1,262Mn vs ₹1,007Mn (▲25.32% YoY). EBITDA Margin 7.58% vs 12.40% (▼482bps).

EPL Limited announced the allotment of 29,316 equity shares of face value Rs. 2 each on May 13, 2026, following the exercise of stock options under its ESOS 2020. This increased the paid-up equity share capital from 32,02,50,343 to 32,02,79,659 shares. The company clarified the allotment is not material.

EPL Limited announced an investor conference call on May 14, 2026, at 5:30 PM (IST) to discuss its Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026 (Q4FY26).

EPL Limited announced on April 23, 2026, the allotment of 2,500 equity shares following the exercise of stock options under its ESOS 2020 scheme. The paid-up equity share capital increased from 32,02,47,843 to 32,02,50,343 shares, with a face value of Rs. 2 each. The company stated this allotment is not material.

New Filing detected. See link for details.